These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 25881770)
1. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis. Parkins MD; Floto RA J Cyst Fibros; 2015 May; 14(3):293-304. PubMed ID: 25881770 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections. Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of microorganisms isolated from sputum culture of patients with cystic fibrosis: Methicillin-resistant Staphylococcus aureus as a serious concern. Mazloomi Nobandegani N; Mahmoudi S; Pourakbari B; Hosseinpour Sadeghi R; Najafi Sani M; Farahmand F; Motamed F; Nabavizadeh Rafsanjani R; Mamishi S Microb Pathog; 2016 Nov; 100():201-204. PubMed ID: 27666507 [TBL] [Abstract][Full Text] [Related]
11. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008. Emerson J; McNamara S; Buccat AM; Worrell K; Burns JL Pediatr Pulmonol; 2010 Apr; 45(4):363-70. PubMed ID: 20232473 [TBL] [Abstract][Full Text] [Related]
12. [Emerging bacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis from a microbiologist's perspective]. Menetrey Q; Dupont C; Chiron R; Marchandin H Rev Mal Respir; 2020 Sep; 37(7):561-571. PubMed ID: 32684338 [TBL] [Abstract][Full Text] [Related]
13. Effects of postage on recovery of pathogens from cystic fibrosis sputum samples. Hatfield L; Bianco B; Gavillet H; Burns P; Rivett D; Smith M; Jones A; van der Gast C; Horsley A J Cyst Fibros; 2023 Sep; 22(5):816-822. PubMed ID: 36934050 [TBL] [Abstract][Full Text] [Related]
14. Microbiology of airway disease in a cohort of patients with cystic fibrosis. Lambiase A; Raia V; Del Pezzo M; Sepe A; Carnovale V; Rossano F BMC Infect Dis; 2006 Jan; 6():4. PubMed ID: 16405721 [TBL] [Abstract][Full Text] [Related]
15. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation. Lobo LJ; Tulu Z; Aris RM; Noone PG Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407 [TBL] [Abstract][Full Text] [Related]
16. New treatments for emerging cystic fibrosis pathogens other than Pseudomonas. Waters V Curr Pharm Des; 2012; 18(5):696-725. PubMed ID: 22229574 [TBL] [Abstract][Full Text] [Related]
17. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods. Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078 [TBL] [Abstract][Full Text] [Related]